PHILADELPHIA, Feb. 11, 2010 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") announces that the Board of Directors of Hemispherx Biopharma, Inc. has approved the recommendations of the Compensation Committee to award bonuses to officers and key executives for performance in relation to their attainment of 2009 of Company-wide goals as well at their achievements in individual goals and responsibilities.
